Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica
View original at finance.yahoo.comRadiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica AstuteAnalytica India Pvt…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
92% of hospitals accredited by the Joint Commission utilize automated dose tracking systems to adhere to the 2024 update of TJC Standard PC.01.03.01
80% confidenceUnited States and Germany together account for 45% of all AI-related patents in radiation dose management
80% confidenceThe global radiation dose management market was valued at US$ 764.2 million in 2024 and is projected to hit the market valuation of US$ 2,301.3 million by 2033 at a CAGR of 13.03% during the forecast period 2025–2033
80% confidenceCT and MRI scans have increased by an average of 12% annually since 2020
80% confidenceCardiac CT scans used for coronary artery screenings in Europe have surged by 25% between 2022 and 2024
80% confidenceHospitals dominate the radiation dose management market, capturing approximately 50% of the share
80% confidenceMedic Vision's FDA-cleared AI platform reduces fluoroscopy time during cardiac procedures by up to 30%
80% confidence68% of U.S. hospitals operate two or more CT scanners
80% confidenceBy 2024, approximately 65% of U.S. hospitals had deployed advanced dose management solutions like Bayer's Radimetrics or GE HealthCare's DoseWatch
80% confidenceThe software segment holds a commanding 70% share of the radiation dose management market
80% confidenceUnited States accounts for approximately 75% of North America's radiation dose management market activity
80% confidenceOnly 53% of outpatient centers have adopted automated dose tracking technologies
80% confidenceSoftware platforms have helped reduce protocol deviation errors by as much as 52%
80% confidence78% of U.S. hospitals had deployed AI-powered dose management systems such as Bayer's Radimetrics and GE HealthCare's DoseWatch by 2024, reflecting a 25% increase in adoption since 2022
80% confidence78% of U.S. hospitals have adopted AI-enabled dose monitoring software in response to the Joint Commission's 2024 imaging safety standards
80% confidence